Atea Pharmaceuticals shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $415k | 143k | 2.90 |
| 2025-06-30 | $515k | 143k | 3.60 |
| 2025-03-31 | $428k | 143k | 2.99 |
| 2024-12-31 | $112k | 33k | 3.35 |
| 2023-09-30 | $1.1M | 380k | 3.00 |
| 2023-06-30 | $1.4M | 380k | 3.74 |
| 2023-03-31 | $1.3M | 380k | 3.35 |
| 2022-12-31 | $1.9M | 388k | 4.81 |
| 2022-09-30 | $2.0M | 356k | 5.69 |
| 2022-06-30 | $2.5M | 348k | 7.10 |
| 2022-03-31 | $193k | 27k | 7.23 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management